Publications by authors named "Miriam Recalde"

Claim this Profile
C
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression.
Idoia Bilbao, Miriam Recalde, Fabrice Daian, José Maria Herranz, María Elizalde

J Physiol Biochem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis.
Carla Rojo, María Gárate-Rascón, Miriam Recalde, Ane Álava, María Elizalde

JHEP Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and Disease.
María Gárate-Rascón, Miriam Recalde, Carla Rojo, Maite G Fernández-Barrena, Matías A Ávila

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis.
Miriam Recalde, María Gárate-Rascón, José María Herranz, María Elizalde, María Azkona

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.
María Gárate-Rascón, Miriam Recalde, Maddalen Jimenez, María Elizalde, María Azkona

Hepatology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation.
Miriam Recalde, María Gárate-Rascón, María Elizalde, María Azkona, M Ujue Latasa

Nucleic Acids Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease.
María Arechederra, Miriam Recalde, María Gárate-Rascón, Maite G Fernández-Barrena, Matías A Ávila

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis.
Marina Barcena-Varela, Hannah Paish, Laura Alvarez, Iker Uriarte, Maria U Latasa, Miriam Recalde

Gut· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis .
Silvia González-Ramos, Victoria Fernández-García, Miriam Recalde, Cristina Rodríguez, José Martínez-González

Cells· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis